Polyphenolic Nanomedicine Regulating Mitochondria REDOX for Innovative Cancer Treatment

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Cancer is a leading global cause of death.
• Mitochondrial dysfunction is a key factor in cancer progression.
• Plant polyphenols possess anticancer properties but suffer from poor stability and bioavailability.

Purpose of the Study:

• To review construction strategies and anticancer properties of polyphenol-based nanomedicines targeting mitochondria.
• To explore how these nanomedicines enhance ROS production and inhibit cancer.
• To discuss the benefits, applications, and future challenges of these therapies.

Main Methods:

• Review of recent literature on polyphenol-based nanomedicines.
• Analysis of various construction strategies including self-assembly, metal-phenol networks, and liposomes.
• Examination of mechanisms involving ROS promotion and mitochondrial targeting.

Main Results:

• Polyphenol nanomedicines demonstrate improved solubility and stability.
• These nanomedicines exhibit efficient photothermal conversion and ion adsorption.
• They effectively regulate mitochondrial homeostasis and promote ROS production for cancer cell death.

Conclusions:

• Polyphenol-based nanomedicines represent a viable strategy for REDOX-targeted mitochondrial cancer therapy.
• Diverse construction methods yield nanomedicines with enhanced anticancer efficacy.
• Further research is needed to address challenges and optimize clinical application.